Company Rexahn Pharmaceuticals, Inc. Nyse
Equities
US7616402001
Biotechnology & Medical Research
Business Summary
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 24,813,370 | 23,942,205 ( 96.49 %) | 0 | 96.49 % |
Company contact information
Rexahn Pharmaceuticals, Inc.
15245 Shady Grove Road Suite 455
20850, Rockville
+(248) 957-9024
http://www.rexahn.comSector
1st Jan change | Capi. | |
---|---|---|
+3.74% | 108B | |
+11.17% | 104B | |
+1.28% | 22.33B | |
-12.72% | 22.19B | |
-7.05% | 18.69B | |
-38.36% | 17.74B | |
-10.47% | 17.64B | |
+3.77% | 14.05B | |
+37.52% | 12.51B |